Association of CDK6 gene polymorphisms with Behcet's disease in a Han Chinese population

Shiya Cai1, Jun Zhang2, Chunya Zhou1

  • 1Department of Ophthalmology, The Second Affiliated Hospital of Fujian Medical University, Engineering Research Center of Assistive Technology for Visual Impairment, Fujian Province University, Quanzhou, PR China; Department of Ophthalmology & Optometry, The School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, PR China.

Insights

Genetic variants in CDK6, specifically rs2282983 and rs42034, are associated with Behcet's disease (BD) susceptibility and skin lesions in the Han Chinese population. These findings offer new insights into the genetic basis of BD.

Area of Science:

  • Genetics
  • Immunology
  • Rheumatology

Background:

  • Cyclin-dependent kinases 4/6 (CDK4/6) and D1-type cyclins (CCND1) play roles in regulating inflammatory responses.
  • Behcet's disease (BD) is a chronic inflammatory disorder with complex etiology.
  • Understanding the genetic factors contributing to BD susceptibility is crucial for elucidating its pathogenesis.

Purpose of the Study:

  • To investigate the association between genetic variants in the CDK4/6-CCND1 pathway and susceptibility to Behcet's disease.
  • To explore the correlation between these genetic variants and clinical manifestations, such as skin lesions, in BD patients.

Main Methods:

  • A case-control study was conducted with 542 BD patients and 754 healthy controls from the Han Chinese population.
  • Fourteen tagged single nucleotide polymorphisms (tag SNPs) in the CDK4/6-CCND1 gene were genotyped using Sequenom MassARRAY and iPLEX® Pro assay.
  • Statistical analyses, including odds ratios and confidence intervals, were performed to assess genetic associations.

Main Results:

  • The CDK6 rs2282983 TT genotype showed a higher frequency in BD patients compared to controls (Pc = 0.040).
  • CDK6 rs2282983 CT and rs42034 AG genotypes were negatively associated with BD susceptibility (Pc = 3.647 × 10⁻⁴ and Pc = 0.039, respectively).
  • CDK6 rs2282983 TT and CT genotypes were significantly associated with the presence of skin lesions in BD patients (Pc = 0.042 and Pc = 0.001, respectively).

Conclusions:

  • The CDK6 loci rs2282983 and rs42034 may confer genetic susceptibility to Behcet's disease in the Han Chinese population.
  • These genetic variations could be linked to specific clinical features, such as skin lesions.
  • The findings provide novel insights into the genetic underpinnings and pathogenesis of Behcet's disease.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.7K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K